David Westenberg
Stock Analyst at Piper Sandler
(4.18)
# 489
Out of 4,623 analysts
135
Total ratings
56.32%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by David Westenberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Initiates: Neutral | $235 | $216.39 | +8.60% | 1 | Oct 1, 2024 | |
| NTRA Natera | Reiterates: Overweight | $150 | $130.06 | +15.33% | 12 | Sep 13, 2024 | |
| EXAS Exact Sciences | Maintains: Overweight | $75 → $85 | $70.96 | +19.79% | 8 | Sep 12, 2024 | |
| ZTS Zoetis | Maintains: Overweight | $195 → $210 | $190.08 | +10.48% | 11 | Aug 14, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $600 → $520 | $476.27 | +9.18% | 8 | Aug 14, 2024 | |
| GH Guardant Health | Maintains: Overweight | $30 → $34 | $21.40 | +58.88% | 7 | Aug 13, 2024 | |
| ILMN Illumina | Maintains: Overweight | $200 → $195 | $145.54 | +33.98% | 13 | Aug 13, 2024 | |
| CTKB Cytek Biosciences | Maintains: Overweight | $8.5 → $8 | $5.01 | +59.68% | 7 | Aug 13, 2024 | |
| AKYA Akoya Biosciences | Maintains: Overweight | $6 → $4 | $3.00 | +33.33% | 6 | Aug 13, 2024 | |
| TEM Tempus AI | Initiates: Neutral | $40 | $48.82 | -18.07% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $18 | $14.43 | +21.28% | 9 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $145 → $150 | $148.67 | +0.89% | 4 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $16 | $14.37 | +11.34% | 8 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $2 | $1.98 | +1.01% | 5 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $28 → $25 | $19.84 | +26.01% | 5 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $18 → $20 | $13.53 | +47.82% | 7 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $3 | $3.05 | -1.64% | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $6 | $4.94 | +21.46% | 10 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $44 | $30.87 | +42.53% | 2 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $16.26 | - | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $41.05 | - | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $49.03 | - | 1 | Nov 21, 2017 |
Labcorp Holdings
Oct 1, 2024
Initiates: Neutral
Price Target: $235
Current: $216.39
Upside: +8.60%
Natera
Sep 13, 2024
Reiterates: Overweight
Price Target: $150
Current: $130.06
Upside: +15.33%
Exact Sciences
Sep 12, 2024
Maintains: Overweight
Price Target: $75 → $85
Current: $70.96
Upside: +19.79%
Zoetis
Aug 14, 2024
Maintains: Overweight
Price Target: $195 → $210
Current: $190.08
Upside: +10.48%
IDEXX Laboratories
Aug 14, 2024
Maintains: Neutral
Price Target: $600 → $520
Current: $476.27
Upside: +9.18%
Guardant Health
Aug 13, 2024
Maintains: Overweight
Price Target: $30 → $34
Current: $21.40
Upside: +58.88%
Illumina
Aug 13, 2024
Maintains: Overweight
Price Target: $200 → $195
Current: $145.54
Upside: +33.98%
Cytek Biosciences
Aug 13, 2024
Maintains: Overweight
Price Target: $8.5 → $8
Current: $5.01
Upside: +59.68%
Akoya Biosciences
Aug 13, 2024
Maintains: Overweight
Price Target: $6 → $4
Current: $3.00
Upside: +33.33%
Tempus AI
Aug 12, 2024
Initiates: Neutral
Price Target: $40
Current: $48.82
Upside: -18.07%
Aug 6, 2024
Maintains: Neutral
Price Target: $17 → $18
Current: $14.43
Upside: +21.28%
Jul 29, 2024
Maintains: Neutral
Price Target: $145 → $150
Current: $148.67
Upside: +0.89%
Jul 1, 2024
Maintains: Neutral
Price Target: $19 → $16
Current: $14.37
Upside: +11.34%
May 13, 2024
Maintains: Neutral
Price Target: $6.5 → $2
Current: $1.98
Upside: +1.01%
Mar 6, 2024
Maintains: Neutral
Price Target: $28 → $25
Current: $19.84
Upside: +26.01%
Feb 26, 2024
Maintains: Overweight
Price Target: $18 → $20
Current: $13.53
Upside: +47.82%
Nov 13, 2023
Maintains: Neutral
Price Target: $3.5 → $3
Current: $3.05
Upside: -1.64%
Nov 13, 2023
Maintains: Overweight
Price Target: $13 → $6
Current: $4.94
Upside: +21.46%
Jun 25, 2020
Maintains: Buy
Price Target: $34 → $44
Current: $30.87
Upside: +42.53%
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $16.26
Upside: -
Jan 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $41.05
Upside: -
Nov 21, 2017
Initiates: Neutral
Price Target: n/a
Current: $49.03
Upside: -